Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma

OBJECTIVES: Gemcitabine and cisplatin (GC) is an active combination in the treatment of metastatic bladder cancer. We have prospectively analyzed the efficacy and tolerability of GC as neoadjuvant treatment of invasive bladder cancer MATERIALS AND METHODS: In this single-institution phase II trial,...

Full description

Bibliographic Details
Main Authors: Daniel Herchenhorn, Rodrigo Dienstmann, Fabio A. Peixoto, Franz S. de Campos, Valdelice O. Santos, Denise M. Moreira, Hedilene Cardoso, Isabele A. Small, Carlos G. Ferreira
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2007-10-01
Series:International Brazilian Journal of Urology
Subjects:
bladder neoplasms
neoadjuvant therapy
cisplatin
gemcitabine
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000500004

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000500004

Similar Items